Shulin Chen

58 Zhongshan Road 2
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Development and validation of a novel model based on hematological biomarkers for predicting risk factors and outcomes in cancer patients with carbapenem-resistant organism infection.

Development and validation of a novel model based on hematological biomarkers for predicting risk factors and outcomes in cancer patients with carbapenem-resistant organism infection.

Journal: Frontiers in public health
Published: October 28, 2025

Establishing and validating models integrated with hematological biomarkers and clinical characteristics for the prognosis of non-esophageal squamous cell carcinoma patients.

Establishing and validating models integrated with hematological biomarkers and clinical characteristics for the prognosis of non-esophageal squamous cell carcinoma patients.

Journal: Annals of medicine
Published: March 28, 2025

A novel model for predicting immunotherapy response and prognosis in NSCLC patients.

A novel model for predicting immunotherapy response and prognosis in NSCLC patients.

Journal: Cancer cell international
Published: January 20, 2025

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit.

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit.

Journal: Journal of hepatocellular carcinoma
Published: December 25, 2024

A novel prognostic model to predict prognosis of patients with osteosarcoma based on clinical characteristics and blood biomarkers.

A novel prognostic model to predict prognosis of patients with osteosarcoma based on clinical characteristics and blood biomarkers.

Journal: Journal of Cancer
Published: October 21, 2024

Mapk7 enhances osteogenesis and suppresses adipogenesis by activating Lrp6/β-catenin signaling axis in mesenchymal stem cells.

Mapk7 enhances osteogenesis and suppresses adipogenesis by activating Lrp6/β-catenin signaling axis in mesenchymal stem cells.

Journal: Communications biology
Published: April 04, 2024

Establishing and Validating a novel Prognostic Model in the Initial Diagnosis of Non-small Cell Lung Cancer with Bone Metastases.

Establishing and Validating a novel Prognostic Model in the Initial Diagnosis of Non-small Cell Lung Cancer with Bone Metastases.

Journal: Journal of Cancer
Published: February 28, 2024

A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.

A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.

Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2023

Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities.

Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities.

Journal: Life sciences
Published: February 17, 2023

T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma.

T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 19, 2022

M13, an anthraquinone compound isolated from Morinda officinalis promotes the osteogenic differentiation of MSCs by targeting Wnt/β-catenin signaling.

M13, an anthraquinone compound isolated from Morinda officinalis promotes the osteogenic differentiation of MSCs by targeting Wnt/β-catenin signaling.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 19, 2022

Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma.

Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma.

Journal: Cancer cell international
Published: June 21, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026